Euro Roundup: EMA seeks feedback on planned changes to guidance on biosimilar efficacy studies

23 Jul 2026 Study: Most sponsors complete postmarketing trials, publish results Postmarketing requirements and commitments were completed for nearly nine out of ten drugs approved by the US Food and Drug Administration, with such requirements or commitments assigned at the time of approval. Of those, the vast majority of study results were published in ClinicalTrials.gov or another publication, according to an article published Thursday in JAMA Network Open. Regulatory News